Hepatobiliopancreatic surgery: Different surgical techniques tailored to each patient´s pathology
Study summary
The main aims of this study are:
1. \- to evaluate post-surgical morbidity and mortality outcomes, following the criteria and the definitions from Claven-Dindo and ISGPS international classifications, of the patients operated by the HPB Surgical Unit.
2. \- to evaluate survival and disease-free survival rates of the patients operated by the HPB Surgical Unit due to tumoral cause.
Eligibility
Sex
ALL
Min age
15 Years
Max age
90 Years
Healthy volunteers
No
Inclusion Criteria:
* All patients operated by the HPB Surgical Unit in the last 10 years (retrospective)
* All patients being operated by the HPB Surgical Unit from January 2019 onwards who provide inform consent (prospective).
Exclusion Criteria:
* Patients not eligible for surgery
* Patients not interested in taking part in the study
Primary outcome measure(s)
Rate of patient with post-surgical morbidity and mortality operated by the HPB Surgical Unit — 90 days post-surgery Morbidity and mortality outcomes are evaluated following the criteria and definitions from Claven-Dindo and ISGPS international classifications
Survival rate of patients operated by the HPB Surgical Unit — 5-years post-surgery These patients are operated due to tumoral cause
Disease-free survival rate of patients operated by the HPB Surgical Unit — 5-years post-surgery These patients are operated due to tumoral cause
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.